SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-053381
Filing Date
2023-10-23
Accepted
2023-10-23 18:31:03
Documents
2
Period of Report
2023-10-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1611
2 POA DOCUMENT poa.txt EX-24 3447
  Complete submission text file 0001209191-23-053381.txt   6591
Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Issuer) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CENTESSA PHARMACEUTICALS PLC D. HODGKIN BLDG, BABRAHAM RSRCH CAMPUS CAMBRIDGE X0 CB22 3FH
Business Address
KANTOFF AARON (Reporting) CIK: 0001862734 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40384 | Film No.: 231340775